Mast cell leukemia- A rare case reported

Disha Bipinbhai Patel, Shilpa Gandhi, Gauravi A. Dhruva
{"title":"Mast cell leukemia- A rare case reported","authors":"Disha Bipinbhai Patel, Shilpa Gandhi, Gauravi A. Dhruva","doi":"10.18231/j.ijpo.2024.016","DOIUrl":null,"url":null,"abstract":"Mast cell leukemia is a rare and aggressive clonal disorder of mast cells & their precursor cells. Systemic mastocytosis clinical course ranging from cutaneous mastocytosis, indolent disease, mast leukaemia and multisystem involvement. 14 Y/M presented with skin coloured plaque present over whole body with itching. On histopathological evaluation of skin lesion cutaneous mastocytosis was diagnosed. Further evaluation for systemic involvement by bone marrow aspiration was carried out, which shows hypercellular marrow for age, erythropoiesis and megakaryopoiesis within normal limits. The differential count revealed 70% of all nucleated cells were mast cells, with many large aggregates of >15% cells and 20% atypical mast cells seen as suggestive of MAST CELL LEUKEMIA (Aleukemic leukemia). S.trptase level >200ng/ml.: The presence of the major criteria-bone marrow at least 20% atypical immature mast cell with least ≥15 multifocal dense Mast cells in bone marrow or extracutaneous organ, in addition to at least one minor criterion: 1) presence of atypical morphology in more than 25% Bone marrow or extracellular mast cells 2) Serum tryptase>20ng/ml. 3) Bone marrow, blood or extracutaneous organs: (a) CD2 and/or CD25 positive (b) Detection of KIT mutation at codon 816.: Considering characteristic bone marrow feature, and with biochemical and radiological investigation mast cell leukemia was diagnosed which helping clinicians to plan further management.  ","PeriodicalId":486471,"journal":{"name":"Indian Journal of Pathology and Oncology","volume":"6 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Pathology and Oncology","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.18231/j.ijpo.2024.016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Mast cell leukemia is a rare and aggressive clonal disorder of mast cells & their precursor cells. Systemic mastocytosis clinical course ranging from cutaneous mastocytosis, indolent disease, mast leukaemia and multisystem involvement. 14 Y/M presented with skin coloured plaque present over whole body with itching. On histopathological evaluation of skin lesion cutaneous mastocytosis was diagnosed. Further evaluation for systemic involvement by bone marrow aspiration was carried out, which shows hypercellular marrow for age, erythropoiesis and megakaryopoiesis within normal limits. The differential count revealed 70% of all nucleated cells were mast cells, with many large aggregates of >15% cells and 20% atypical mast cells seen as suggestive of MAST CELL LEUKEMIA (Aleukemic leukemia). S.trptase level >200ng/ml.: The presence of the major criteria-bone marrow at least 20% atypical immature mast cell with least ≥15 multifocal dense Mast cells in bone marrow or extracutaneous organ, in addition to at least one minor criterion: 1) presence of atypical morphology in more than 25% Bone marrow or extracellular mast cells 2) Serum tryptase>20ng/ml. 3) Bone marrow, blood or extracutaneous organs: (a) CD2 and/or CD25 positive (b) Detection of KIT mutation at codon 816.: Considering characteristic bone marrow feature, and with biochemical and radiological investigation mast cell leukemia was diagnosed which helping clinicians to plan further management.  
肥大细胞白血病--罕见病例报告
肥大细胞白血病是肥大细胞及其前体细胞的一种罕见的侵袭性克隆疾病。全身性肥大细胞增多症的临床表现包括皮肤肥大细胞增多症、轻度疾病、肥大细胞白血病和多系统受累。14 岁男童全身出现皮肤色斑,伴有瘙痒。对皮肤病变进行组织病理学评估后,确诊为皮肤肥大细胞增多症。通过骨髓抽吸对全身受累情况进行了进一步评估,结果显示骨髓细胞过多(与年龄不符),红细胞生成和巨核细胞生成在正常范围内。鉴别计数显示,70%的有核细胞为肥大细胞,其中许多细胞聚集率大于15%,20%为非典型肥大细胞,提示为肥大细胞白血病(Aleukemic leukemia)。S.triptase水平>200ng/ml:存在主要标准--骨髓中至少有 20% 的不典型未成熟肥大细胞,骨髓或皮外器官中至少有≥15 个多灶性致密肥大细胞,此外还至少存在一个次要标准:1) 超过 25% 的骨髓或细胞外肥大细胞存在非典型形态 2) 血清胰蛋白酶>20ng/ml。3)骨髓、血液或皮外器官:(a)CD2 和/或 CD25 阳性(b)检测到 KIT 密码子 816 突变:考虑到骨髓特征,以及生化和放射学检查,肥大细胞白血病被确诊,这有助于临床医生制定进一步的治疗方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信